2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Monday, December 14, 2026
06:00 p.m. - 08:00 p.m.
MCCNO - Hall F
Access, Representation, Population Health, Technology and Procedures, Blood Banking, Clinical Procedures, Treatment Considerations, Combination Therapy, Drug Development, Drug-Drug Interactions, Supportive Care, Therapy Sequence, Biological Therapies, Transfusion, Vaccines, Non-Biological Therapies, Opioids, Women’s Health, Adverse Events, Biological Processes, Hematopoiesis, Metabolism, Clinical Practice (Health Services and Quality), Patient Safety, Quality Improvement, Quality of Care, Systems-Based Hematology, Diseases, Bleeding and Clotting, Thromboembolism, Thrombotic Disorders, Genetic Disorders, Hemoglobinopathies, Sickle Cell Disease, Sickle Cell Trait, Thalassemia, Immunology, Immunodeficiency, Infectious Diseases, Bacterial, Research, Clinical Research, Clinical Trials, Epidemiology, Health Outcomes Research, Health Disparities Research, Patient-Reported Outcomes, Real-World Evidence, Registries, Study Population, Human, Adult, Pediatric, Young Adult
PAPER

4679 Higher urinary soluble klotho is associated with higher estimated glomerular filtration rates but worsening albuminuria in adults with sickle cell disease: A tubular marker complementary to albuminuria

Kabir Olaniran, MD, MPH, Johanne Pastor2, Robert Toto3, Orson W. Moe, MD4
1 University of Texas Southwestern Medical Center, Dallas, Texas, United States
2 University of Texas Southwestern Medical Center, Dallas, Texas, United States
3 University of Texas Southwestern Medical Center, Dallas, Texas, United States
4 University of Texas Southwestern Medical Center, Dallas, Texas, United States

Background
Chronic kidney disease (CKD) is a highly prevalent and early complication of sickle cell disease (SCD), typically presenting as albuminuria. Persistent albuminuria in SCD predicts subsequent estimated glomerular filtration rate (eGFR) decline and increased mortality. However, albuminuria is primarily a glomerular readout that may not adequately capture kidney tubular health, which is compromised in SCD by recurrent ischemia-reperfusion injury, amongst other insults. Soluble Klotho (sKlotho), a kidney tubular-derived protein shed into both serum and urine, has been linked to kidney tubular oxidative stress and fibrosis. sKlotho is also implicated in preserving the glomerular filtration barrier integrity, whose compromise contributes to persistent albuminuria. In mice, kidney tubular segment-specific deletions indicate urinary sKlotho is largely derived from the distal tubules and not filtered from serum, while the proximal tubule is a possible principal source of serum sKlotho. We examined paired serum and urinary sKlotho as a kidney tubular probe in SCD-associated CKD.

Methods
We performed a cross-sectional analysis on a prospective cohort of 60 adults with SCD in Dallas, Texas as part of the Sickle Cell Kidney Study (NCT07064174). All clinical data, blood and urine samples were collected ≥2 weeks after an acute pain episode, ≥3 weeks after a simple transfusion, ≥4 weeks postpartum, or immediately before scheduled transfusion therapy. Persistent albuminuria was confirmed on follow up testing. Paired serum sKlotho and creatinine-normalized urine sKlotho (sKlotho/Cr) were measured by validated methods and correlated with urine albumin-to-creatinine ratio (uACR) and eGFR by creatinine and cystatin C (eGFRcr and eGFRcys) using multivariable linear regression adjusted for age, sex, systolic blood pressure (SBP), hemoglobin, and the reciprocal kidney measure. sKlotho levels, uACR, and lactate dehydrogenase (LDH) were log-transformed. Spearman rank correlation was used to assess associations between serum and urine sKlotho. Trend across uACR categories (<30, 30-299, ≥300 mg/g) was assessed using nonparametric tests for ordered groups for urine and serum sKlotho.

Results
The mean age was 40±10 years, 60% were female, 70% HbSS genotype, 27% HbSC genotype and 3% HbSb+. The mean SBP was 120±15 mmHg. Sixty percent were on hydroxyurea and 10% on transfusion therapy. The mean hemoglobin was 9.5±2.2 g/dL, eGFRcr was 106±24 mL/min/1.73m2, eGFRcys was 86±27 mL/min/1.73m2, median LDH was 377 (interquartile range 259-485), 37% had persistent uACR 30-299 mg/g, and 22% persistent uACR ≥300 mg/g.
Higher urine sKlotho/Cr was significantly associated with higher uACR (β=0.95; 95% confidence interval [CI] 0.45-1.44), higher eGFRcr (β=7.20; 95% CI 1.27-13.13) and higher eGFRcys (β=11.21; 95% CI 3.17-19.24) after adjustment. In contrast, serum sKlotho was not  associated with uACR (β= -0.33; 95% CI -1.11 to 0.45), eGFRcr (β=1.63, 95% CI -6.55 to 9.81) or eGFRcys (β=9.41; 95% CI -1.56 to 20.39). Urine sKlotho/Cr and serum sKlotho were not correlated with each other (rho=0.12; p=0.37). Median urine sKlotho/Cr increased across increasing uACR categories from 2.2 to 3.8 to 7.7 pmoles/mmoles (p for trend <0.001). In contrast, serum sKlotho showed a modest, non-significant decline in median concentrations across the same uACR categories (p for trend = 0.073). On exploratory univariate linear regression analysis of determinants of sKlotho measures, lower hemoglobin, higher LDH, and higher uACR, were significantly associated with higher urine sKlotho/Cr. No variables were significantly associated with serum sKlotho on univariate analysis.

Conclusions
The graded rise in urine sKlotho/Cr across uACR categories and its associations with hemoglobin, LDH and continuous uACR are consistent with a model of increased tubular sKlotho release accompanying hemolysis in SCD. That urine sKlotho/Cr rose with both uACR and higher eGFR raises the possibility that it captures an early tubular stress state rather than advanced nephron loss. That serum sKlotho and urine sKlotho/Cr were uncorrelated highlights urine sKlotho/Cr as a distinct tubular readout rather than a passive reflection of serum sKlotho. These findings suggest urine sKlotho/Cr can potentially serve as a candidate biomarker of early sickle cell nephropathy, complementary to albuminuria. Longitudinal studies are needed to determine whether urine sKlotho/Cr predicts subsequent eGFR decline in SCD.

Kabir Olaniran, MD, MPH: No relevant conflicts of interest to declare.